More importantly, we observed that MLC inhibitor could not block the activation of Rac1 induced by CCL2-CCR4; however, it could inhibit the phosphorylation of MLC and suppress cell migration in HNSCC cells. Here, CCL2 is linked to head and neck squamous cell carcinoma.